Adage Capital Partners’s RAPT Therapeutics RAPT Stock Holding History

Adage Capital Partners’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-275,000	Closed	-$9.31M	–	1056
2025 Q4	$9.31M	Buy	+275,000	New	+$8.54M	0.01%	679

Adage Capital Partners's RAPT Position: Q1 2026 in Review

Adage Capital Partners sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 275,000 shares — an estimated $9.31M sold.

Adage Capital Partners first reported a position in RAPT in Q4 2025 and held it in 1 quarter. The position peaked at $9.31M in Q4 2025. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.

Adage Capital Partners reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
Adage Capital Partners sold 275,000 RAPT Therapeutics shares in Q1 2026, an estimated $9.31M.
Adage Capital Partners first reported a position in RAPT Therapeutics in Q4 2025 and held it in 1 quarter.
Adage Capital Partners's RAPT Therapeutics position peaked at $9.31M in Q4 2025.
0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.

Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.